In an effort to get the U.S. government to recognize the value of natural immunity in providing effective protection against COVID-19, U.S. Representative Diana Harshbarger of Tennessee introduced the Natural Immunity Is Real Act in the House of Representatives on Oct. 18, 2021. The bill, H.R. 5590, requires U.S. federal agencies to take into account […]
Following reports of an increased risk of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining of the heart) in young adults after receiving Moderna/NIAID’s experimental messenger RNA (mRNA) COVID-19 biologic known as “Spikevax,” the governments of Denmark, Norway and Sweden have suspended the shot or will not make it available for […]
A new retrospective observational study conducted by researchers at Tel Aviv University and Maccabi Healthcare in Israel found that unvaccinated individuals who developed an infection with the SARS-CoV-2 virus were considerably more protected against the Delta variant of the virus than those who had received two doses of the Pfizer/BioNTech’s experimental messenger RNA (mRNA) biologic […]
On June 23, 2021, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) determined that there is a “likely association” between reported cases of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the membrane surrounding the heart) following vaccination with experimental messenger RNA (mRNA) biologics for COVID-19 […]
On June 2, 2021, the Israeli Ministry of Health announced that it believes there is a “probable link” between Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 and dozens of cases of myocarditis (inflammation of the heart) in Israel—mostly in males between 16-30 years of age. According to an epidemiological study undertaken by a […]